ArticleBritish journal of cancer2024

The SRC-family serves as a therapeutic target in triple negative breast cancer with acquired resistance to chemotherapy.

Eivind Valen Egeland et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.